• S&P 500: 1,342.64
  • Change: -0.69%
$33.77 -1.04 (-2.99%)
2/10/2012 4:04 PM

Charles River Laboratories (NYSE:CRL)

CAPS Rating: 4 out of 5

The Company is a global provider of solutions that advance the drug discovery and development process. It provides the animal research models required in research and development for new drugs, devices and therapies.

Current Price $33.77 Mkt Cap $1.73B
Open $34.51 P/E Ratio 0.00
Prev. Close $34.81 Div. (Yield) N/A (N/A)
Daily Range $33.67 - $34.57 Volume 273,566
52-Wk Range $25.52 - $42.84 Avg. Daily Vol. 0

Caps

How do you think CRL will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

241 Outperform
11 Underperform
 

All-Star Players

80 Outperform
3 Underperform
 

Wall Street

8 Outperform
1 Underperform
 

Top CRL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

HarryCarysGhost (99.65)
Submitted June 26, 2010

Charles River Laboratories International.While channel surfing some random pundit mentioned this stock as one of four that would make you money in 2011. Since I’ve never heard of it some digging was in order.Ok lets see what we got here- a Large Cap… More

EBStroke (< 20)
Submitted November 26, 2008

Pessimistic recet outlook on 2009 Pharma spending. Re-look @ $19

CRL VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about CRL.

Recs

0
Member Avatar MJKpayday (99.63) Submitted: 10/10/2011 9:43:36 AM : Outperform Start Price: $28.46 CRL Score: +4.84

I'm picking this stock because I haven't made a pick in over 90 days and I've heard some good things on one of the services about it.

Recs

0
Member Avatar kenjotto (60.37) Submitted: 8/10/2011 10:16:21 AM : Outperform Start Price: $30.59 CRL Score: -8.58

Activist inspired turn around is progressing well. They're repurchasing shares, cutting underperforming segments, and increasing and improving their sales to key end users. As big pharma looks to revive its pipeline, they'll come to CRL. Plus, CRL is only #2 in the CRO industry, so they have runway ahead of them!

Recs

0
Member Avatar HealthcareGuy (97.83) Submitted: 4/1/2011 4:00:23 PM : Outperform Start Price: $39.83 CRL Score: -16.19

Inflection pt in preclinical CRO activity

Leaderboard

Find the members with the highest scoring picks in CRL.

Score Leader

rahim87

rahim87 (< 20) Score: +51.07

The Score Leader is the player with the highest score across all their picks in CRL.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
rahim87 < 20 6/19/2008 Underperform 3M $64.20 -47.40% +3.67% +51.07 0 Comment
dwotBuyback < 20 1/28/2008 Underperform 5Y $62.46 -45.93% +5.08% +51.01 0 Comment
rlaw02 55.16 5/8/2008 Underperform 1Y $64.37 -47.54% -0.32% +47.21 0 Comment
vrncrn1974 < 20 3/13/2008 Underperform 3W $57.21 -40.97% +6.19% +47.16 0 Comment
MARIO1800 < 20 3/19/2008 Underperform 5Y $56.56 -40.29% +4.39% +44.68 0 Comment
39272x6 < 20 11/10/2009 Underperform 5Y $33.60 +0.51% +22.92% +22.41 0 Comment
JeffHensel 42.29 11/16/2006 Underperform 1Y $42.22 -20.01% +1.25% +21.26 0 Comment
Hamiltionian 45.77 12/14/2011 Outperform 5Y $26.10 +29.39% +10.36% +19.03 0 Comment
ResearchLover < 20 12/29/2011 Outperform 5Y $27.20 +24.15% +6.73% +17.43 0 Comment
NinjaJew 88.91 12/27/2010 Underperform 1Y $35.75 -5.54% +7.38% +12.92 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackZacks 71.25 8/24/2011 Outperform 3M $32.94 -10.53% +6.92% -17.45 11/3/2011 @ $29.47 1 Comment
TrackZacks 71.25 8/4/2011 Underperform 3M $34.06 -3.29% -1.81% +1.48 8/24/2011 @ $32.94 1 Comment
TrackBBTCapMkts 92.62 7/14/2011 Outperform NS $40.95 -17.53% +1.66% -19.19 0 Comment
TrackDreman 90.16 6/30/2010 Outperform NS $34.21 -1.29% +32.78% -34.06 0 Comment
TrackVanDenBerg 95.94 3/31/2010 Outperform NS $39.31 -14.09% +17.12% -31.21 0 Comment
TrackDeutscheSec 90.44 3/4/2010 Outperform NS $39.41 -7.59% +13.45% -21.03 1/7/2011 @ $36.42 0 Comment
TrackBWS 81.16 5/11/2009 Outperform NS $27.97 +15.87% +10.20% +5.67 8/10/2009 @ $32.41 0 Comment
TrackBobOlstein 87.86 3/2/2009 Outperform 1Y $24.36 +45.89% +72.66% -26.76 12/31/2010 @ $35.54 2 Comments
TrackPatDorsey 94.91 2/20/2009 Outperform 5Y $26.30 +28.40% +76.60% -48.20 0 Comment
TrackUBS 93.35 1/30/2009 Underperform NS $25.53 +32.28% +60.91% +28.63 0 Comment
TrackBarclaysCap 93.36 1/20/2009 Outperform NS $26.02 +29.55% +30.45% -0.89 11/9/2009 @ $33.71 0 Comment
TrackUBS 93.35 2/4/2008 Outperform NS $64.99 -60.72% -39.10% -21.62 1/30/2009 @ $25.53 0 Comment
TrackTobinSmith < 20 11/23/2007 Outperform 1Y $62.81 -46.23% -2.33% -43.90 0 Comment
TrackUBS 93.35 10/3/2007 Outperform NS $57.35 +9.87% -1.87% +11.74 12/12/2007 @ $63.01 0 Comment
TrackDreman 90.16 9/30/2007 Outperform NS $56.15 -1.10% -23.98% +22.88 9/30/2008 @ $55.53 2 Comments
TrackRichAster 98.72 9/30/2007 Outperform NS $56.15 -39.86% -7.74% -32.12 2 Comments
TrackRonBaron 89.92 9/30/2007 Outperform NS $56.15 -1.10% -24.59% +23.49 9/30/2008 @ $55.53 1 Comment
TrackRWBaird 90.56 5/2/2007 Outperform NS $49.70 -32.05% -4.60% -27.45 0 Comment
TrackLehmanBros 86.48 4/17/2007 Outperform NS $48.51 -30.39% -3.36% -27.03 0 Comment
TrackJefferies 84.73 2/15/2007 Outperform NS $47.50 -41.62% -41.55% -0.07 4/20/2009 @ $27.73 0 Comment
TrackBofASec 96.91 2/7/2007 Outperform NS $45.97 +12.36% +3.62% +8.73 6/28/2007 @ $51.65 0 Comment

Featured Broker Partners